• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Elife . Identification of a conserved S2 epitope present on spike proteins from all highly pathogenic coronaviruses

tetano

Editor, Senior Moderator
Elife


. 2023 Mar 21;12:e83710.
doi: 10.7554/eLife.83710.
Identification of a conserved S2 epitope present on spike proteins from all highly pathogenic coronaviruses


Rui P Silva[SUP] #[/SUP][SUP] 1 [/SUP], Yimin Huang[SUP] #[/SUP][SUP] 1 [/SUP], Annalee W Nguyen[SUP] #[/SUP][SUP] 2 [/SUP], Ching-Lin Hsieh[SUP] 1 [/SUP], Oladimeji S Olaluwoye[SUP] 3 [/SUP], Tamer S Kaoud[SUP] 4 [/SUP], Rebecca E Wilen[SUP] 2 [/SUP], Ahlam N Qerqez[SUP] 2 [/SUP], Jun-Gyu Park[SUP] 5 6 [/SUP], Ahmed M Khalil[SUP] 5 [/SUP], Laura R Azouz[SUP] 2 [/SUP], Kevin C Le[SUP] 2 [/SUP], Amanda L Bohanon[SUP] 1 [/SUP], Andrea M DiVenere[SUP] 2 [/SUP], Yutong Liu[SUP] 2 [/SUP], Alison G Lee[SUP] 1 [/SUP], Dzifa A Amengor[SUP] 1 [/SUP], Sophie R Shoemaker[SUP] 7 [/SUP], Shawn M Costello[SUP] 8 [/SUP], Eduardo A Padlan[SUP] 9 [/SUP], Susan Marqusee[SUP] 7 10 [/SUP], Luis Martinez-Sobrido[SUP] 5 [/SUP], Kevin N Dalby[SUP] 4 [/SUP], Sheena D'Arcy[SUP] 3 [/SUP], Jason S McLellan[SUP] 1 11 [/SUP], Jennifer A Maynard[SUP] 2 11 [/SUP]



Affiliations

Abstract

To address the ongoing SARS-CoV-2 pandemic and prepare for future coronavirus outbreaks, understanding the protective potential of epitopes conserved across SARS-CoV-2 variants and coronavirus lineages is essential. We describe a highly conserved, conformational S2 domain epitope present only in the prefusion core of β-coronaviruses: SARS-CoV-2 S2 apex residues 980-1006 in the flexible hinge. Antibody RAY53 binds the native hinge in MERS-CoV and SARS-CoV-2 spikes on the surface of mammalian cells and mediates antibody-dependent cellular phagocytosis and cytotoxicity against SARS-CoV-2 spike in vitro. Hinge epitope mutations that ablate antibody binding compromise pseudovirus infectivity, but changes elsewhere that affect spike opening dynamics, including those found in Omicron BA.1, occlude the epitope and may evade pre-existing serum antibodies targeting the S2 core. This work defines a third class of S2 antibody while providing insights into the potency and limitations of S2 core epitope targeting.

Keywords: MERS-CoV; S2 core; S2 hinge; SARS-CoV-2; biochemistry; chemical biology; coronavirus; spike; viruses.
 
Back
Top Bottom